Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Approva Medical was a medical device company focused on developing minimally invasive solutions for the treatment of mitral valve regurgitation. The company's primary technology was a percutaneous heart valve repair system designed to provide a less invasive alternative to traditional open-heart surgery for patients suffering from heart failure. By utilizing a catheter-based approach, Approva aimed to reduce recovery times and improve clinical outcomes for high-risk cardiac patients. The company was acquired by Volcano Corporation in 2012 to strengthen its structural heart disease portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Approva.